Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases
摘要:
The 3-aryl-2-cyanoacrylamide scaffold was designed as core pharmacophore for inhibitors of the Dengue and West Nile virus serine proteases (NS2B-NS3). A total of 86 analogs was prepared to study the structure-activity relationships in detail. Thereby, it turned out that the electron density of the aryl moiety and the central double bond have a crucial influence on the activity of the compounds, whereas the influence of substituents of the amide residue is less relevant. The para-hydroxy substituted analog was found to be the most potent inhibitor in this series with a K(i)-value of 35.7 mu M at the Dengue and 44.6 mu M at the West Nile virus protease. The aprotinin competition assay demonstrates a direct interaction of the inhibitor molecule with active centre of the Dengue virus protease. The target selectivity was studied in a counterscreen with thrombin and found to be 2.8:1 in favor of DEN protease and 2.3:1 in favor of WNV protease, respectively. (C) 2011 Elsevier Ltd. All rights reserved.
[EN] AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME<br/>[FR] AGENTS CIBLANT LES AMYLOÏDES ET PROCÉDÉS DE LEUR UTILISATION
申请人:AMYDIS DIAGNOSTICS
公开号:WO2015143185A1
公开(公告)日:2015-09-24
Provided herein is the design and synthesis of novel molecular rotor fluorophores useful for detection of amyloid or amyloid like proteins. The fluorophores are designed to exhibit enhanced fluorescence emission upon associating with amyloid or amyloid like proteins as compared to unbound compound. Also disclosed herein are the methods for treating of diseases associated with an amyloid or amyloid like proteins.
Tetra‐<i>n</i>‐butylammonium Hydroxide (TBAH)–Catalyzed Knoevenagel Condensation: A Facile Synthesis of α‐Cyanoacrylates, α‐Cyanoacrylonitriles, and α‐Cyanoacrylamides
作者:Saeed Balalaie、Morteza Bararjanian
DOI:10.1080/00397910500385258
日期:2006.3.1
Abstract Tetra‐n‐butylammonium hydroxide (TBAH) has been utilized as a novel and efficient catalyst for the Knoevenagelcondensation of aldehydes with acidic methylene compounds such as methyl‐ and ethylcyanoacetate, malononitrile, and cyanoacetamide to afford substituted olefins.
Some cyano-amides and dicyano-glutaconimides derived from pyridine aldehydes
作者:J. S. A. Brunskill
DOI:10.1039/p19720002946
日期:——
2-Cyano-3-pyridylacrylamides, 2-cyano-3-pyridylpropionamides, and salts of 3,5-dicyano-6-hydroxy-4-pyridyl-2-pyridones have been prepared from four pyridine aldehydes and tested for pharmacological and antimicrobial activity. Spectra–structure correlations include evidence that in the acrylamides the carbamoyl and pyridyl groups are trans.
A study of some reactions of the intermediate isolated from the NN-dimethylaniline–tetracyanoethylene reaction
作者:P. G. Farrell、R. K. Wojtowski
DOI:10.1039/j39700001390
日期:——
It was previously suggested that the intermediateisolatedfrom the NN-dimethylaniline–tetracyanoethylenereaction was zwitterionic. Synthetic and spectroscopic studies on this intermediate reported here indicate that a neutral substituted ethane structure is the correct one. The compounds formed by hydrolysis of the intermediate by acid and by base are described.
[EN] METHODS OF DETECTING NEUROLOGICAL DISORDERS VIA BINDING TO PHOSPHORYLATED TAU PROTEIN<br/>[FR] MÉTHODES DE DÉTECTION DE TROUBLES NEUROLOGIQUES PAR LIAISON À UNE PROTÉINE TAU PHOSPHORYLÉE
申请人:SARRAF STELLA
公开号:WO2021055639A1
公开(公告)日:2021-03-25
Provided herein are methods and compositions for determining whether a patient suffers from a neurological disease or disorder is provided, comprising detecting the presence of a phosphorylated tau protein in a tissue of the patient, wherein the detecting comprises contacting the phosphorylated tau protein with a compound described herein.